223 related articles for article (PubMed ID: 18310093)
1. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.
Li GX; Lee HJ; Wang Z; Hu H; Liao JD; Watts JC; Combs GF; Lü J
Carcinogenesis; 2008 May; 29(5):1005-12. PubMed ID: 18310093
[TBL] [Abstract][Full Text] [Related]
2. Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.
Zhang J; Wang L; Li G; Anderson LB; Xu Y; Witthuhn B; Lü J
Nutr Cancer; 2011; 63(5):778-89. PubMed ID: 21614726
[TBL] [Abstract][Full Text] [Related]
3. Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.
Wang L; Bonorden MJ; Li GX; Lee HJ; Hu H; Zhang Y; Liao JD; Cleary MP; Lü J
Cancer Prev Res (Phila); 2009 May; 2(5):484-95. PubMed ID: 19401524
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lü J
Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
[TBL] [Abstract][Full Text] [Related]
5. Persistent p21Cip1 induction mediates G(1) cell cycle arrest by methylseleninic acid in DU145 prostate cancer cells.
Wang Z; Lee HJ; Chai Y; Hu H; Wang L; Zhang Y; Jiang C; Lü J
Curr Cancer Drug Targets; 2010 May; 10(3):307-18. PubMed ID: 20370687
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.
Zhang J; Wang L; Anderson LB; Witthuhn B; Xu Y; Lü J
Cancer Prev Res (Phila); 2010 Aug; 3(8):994-1006. PubMed ID: 20647336
[TBL] [Abstract][Full Text] [Related]
7. Effect of Dietary Methylseleninic Acid and Se-Methylselenocysteine on Carcinogen-Induced, Androgen-Promoted Prostate Carcinogenesis in Rats.
Bosland MC; Schlicht MJ; Deng Y; Lü J
Nutr Cancer; 2022; 74(10):3761-3768. PubMed ID: 35762420
[TBL] [Abstract][Full Text] [Related]
8. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
Hu H; Jiang C; Li G; Lü J
Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells.
Li GX; Hu H; Jiang C; Schuster T; Lü J
Int J Cancer; 2007 May; 120(9):2034-43. PubMed ID: 17230520
[TBL] [Abstract][Full Text] [Related]
10. Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation.
Jiang C; Ganther H; Lu J
Mol Carcinog; 2000 Dec; 29(4):236-50. PubMed ID: 11170262
[TBL] [Abstract][Full Text] [Related]
11. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 76Se-methylselenocysteine compared with that of 77Se-selenomethionine and 82Se-selenite.
Suzuki KT; Doi C; Suzuki N
Toxicol Appl Pharmacol; 2006 Dec; 217(2):185-95. PubMed ID: 17056079
[TBL] [Abstract][Full Text] [Related]
13. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Hu H; Jiang C; Ip C; Rustum YM; Lü J
Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
[TBL] [Abstract][Full Text] [Related]
14. Selenium effects on prostate cell growth.
Menter DG; Sabichi AL; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1171-82. PubMed ID: 11097224
[TBL] [Abstract][Full Text] [Related]
15. Methyl selenium metabolites decrease prostate-specific antigen expression by inducing protein degradation and suppressing androgen-stimulated transcription.
Cho SD; Jiang C; Malewicz B; Dong Y; Young CY; Kang KS; Lee YS; Ip C; Lü J
Mol Cancer Ther; 2004 May; 3(5):605-11. PubMed ID: 15141018
[TBL] [Abstract][Full Text] [Related]
16. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant.
Drake EN
Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336
[TBL] [Abstract][Full Text] [Related]
17. Differential apoptotic response of human cancer cells to organoselenium compounds.
Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
Cancer Chemother Pharmacol; 2010 Aug; 66(3):475-84. PubMed ID: 19940991
[TBL] [Abstract][Full Text] [Related]
18. The Inhibitory Efficacy of Methylseleninic Acid Against Colon Cancer Xenografts in C57BL/6 Mice.
Zeng H; Wu M
Nutr Cancer; 2015; 67(5):831-8. PubMed ID: 26011019
[TBL] [Abstract][Full Text] [Related]
19. Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.
Sinha I; Null K; Wolter W; Suckow MA; King T; Pinto JT; Sinha R
Int J Cancer; 2012 Mar; 130(6):1430-9. PubMed ID: 21500193
[TBL] [Abstract][Full Text] [Related]
20. Response surface methodology optimizes selenium inhibition of prostate cancer PC-3 cell viability.
Whitcomb A; Li X; Lawson J; Christensen M
J Trace Elem Med Biol; 2024 Jul; 84():127414. PubMed ID: 38489924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
